Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Galzin

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
SL 84.0418: a novel, potent and selective alpha-2 adrenoceptor antagonist: in vitro pharmacological profileI Angel, H Schoemaker, S Arbilla, et al.
Biological Psychiatry|March 1, 1987
Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptineM F Poirier, A M Galzin, H Loo, et al.
Psychopharmacology|January 1, 1988
Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine bindingM F Poirier, A M Galzin, C Pimoule, et al.
Journal of Neurochemistry|October 1, 1992
Characterization of the 5-hydroxytryptamine receptor modulating the release of 5-[3H]hydroxytryptamine in slices of the human neocortexA M Galzin, M F Poirier, A Lista, et al.
Bioorganic & Medicinal Chemistry|August 16, 2001
Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT(1B)/5-HT(2A) receptor antagonistsG McCort, C Hoornaert, M Aletru, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
SL 84.0418: a novel, potent and selective alpha-2 adrenoceptor antagonist: in vitro pharmacological profileI Angel, H Schoemaker, S Arbilla, et al.
Biological Psychiatry|March 1, 1987
Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptineM F Poirier, A M Galzin, H Loo, et al.
Psychopharmacology|January 1, 1988
Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine bindingM F Poirier, A M Galzin, C Pimoule, et al.
Journal of Neurochemistry|October 1, 1992
Characterization of the 5-hydroxytryptamine receptor modulating the release of 5-[3H]hydroxytryptamine in slices of the human neocortexA M Galzin, M F Poirier, A Lista, et al.
Bioorganic & Medicinal Chemistry|August 16, 2001
Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT(1B)/5-HT(2A) receptor antagonistsG McCort, C Hoornaert, M Aletru, et al.
Pageof 6